NDC 76282-322

NDC 76282-322

NDC 76282-322 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 76282-322
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 76282-322-05 [76282032205]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-04-26
Marketing End Date2018-09-12

NDC 76282-322-01 [76282032201]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-04-26
Marketing End Date2018-09-12

NDC 76282-322-27 [76282032227]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-03-20
Marketing End Date2018-09-12

NDC 76282-322-18 [76282032218]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-03-20
Marketing End Date2018-09-12

NDC 76282-322-90 [76282032290]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-03-20
Marketing End Date2018-09-12

NDC 76282-322-60 [76282032260]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-03-20
Marketing End Date2018-09-12

NDC 76282-322-30 [76282032230]

GABAPENTIN CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-03-20
Marketing End Date2018-09-12

Drug Details

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.